| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 17 Jun 24 | ADVM Adverum Biotechnologies | Stock Option Common Stock | Grant | Acquire A | No | No | 7.32 | 10,520 | 77.01 k | 10,520 |
| 7 Jun 24 | SLRN Acelyrin | Director Stock Option Common Stock | Grant | Acquire A | No | No | 4.46 | 92,158 | 411.02 k | 92,158 |
| 5 Jun 24 | XENE Xenon Pharmaceuticals | Stock Option Common Shares | Grant | Acquire A | No | No | 38.16 | 15,542 | 593.08 k | 15,542 |
| 24 Aug 23 | XENE Xenon Pharmaceuticals | Common Shares | Sell | Dispose S | No | No | 38.7 | 25,000 | 967.50 k | 25,000 |
